Enterprise Value
15.0M
Cash
1.695M
Avg Qtr Burn
-2.421M
Short % of Float
0.89%
Insider Ownership
41.52%
Institutional Own.
6.46%
Qtr Updated
07/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AL001 Details Post-traumatic stress disorder | Phase 2 Initiation | |
AL001 Details Bipolar disease | Phase 2 Initiation | |
AL001 Details Major depressive disorder | Phase 2 Initiation | |
AL001 Details Alzheimer's disease | Phase 2 Initiation | |
ALZN002 Details Alzheimer's disease, Dementia | Phase 1/2 Data readout |